Cargando…

Safety of early norepinephrine infusion through peripheral vascular access during transport of critically ill children

STUDY OBJECTIVE: In prehospital and emergency settings, vasoactive medications may need to be started through a peripheral intravenous catheter. Fear of extravasation and skin injury, with norepinephrine specifically, may prevent or delay peripheral vasopressor initiation, though studies from adults...

Descripción completa

Detalles Bibliográficos
Autores principales: Charbel, Ramy C., Ollier, Vincent, Julliand, Sebastien, Jourdain, Gilles, Lode, Noëlla, Tissieres, Pierre, Morin, Luc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926000/
https://www.ncbi.nlm.nih.gov/pubmed/33718927
http://dx.doi.org/10.1002/emp2.12395
_version_ 1783659374805254144
author Charbel, Ramy C.
Ollier, Vincent
Julliand, Sebastien
Jourdain, Gilles
Lode, Noëlla
Tissieres, Pierre
Morin, Luc
author_facet Charbel, Ramy C.
Ollier, Vincent
Julliand, Sebastien
Jourdain, Gilles
Lode, Noëlla
Tissieres, Pierre
Morin, Luc
author_sort Charbel, Ramy C.
collection PubMed
description STUDY OBJECTIVE: In prehospital and emergency settings, vasoactive medications may need to be started through a peripheral intravenous catheter. Fear of extravasation and skin injury, with norepinephrine specifically, may prevent or delay peripheral vasopressor initiation, though studies from adults suggest the actual risk is low. We sought to study the risk of extravasation and skin injury with peripheral administration of norepinephrine in children in the prehospital setting. METHODS: We performed a retrospective study of pediatric patients (≤18 years) who received a vasopressor during prehospital transport. We collected data from retrieval and hospital records from 2 pediatric medical retrieval teams in the Paris/Ile‐de‐France region. Patients were eligible if they had documentation of distributive or obstructive shock and administration of norepinephrine through a peripheral catheter (intravenous or intraosseous) during retrieval. The primary outcomes were the occurrence of extravasation and evidence of skin injury. We also examined approach to norepinephrine administration (concentration, duration, proximal vs distal site) and hospital outcomes. RESULTS: Over a 3‐year‐period, 37 pediatric patients received norepinephrine through a peripheral catheter (33 intravenous, 4 intraosseous). Median patient age was 1.8 years. Thirty‐two patients (86.5%) had septic shock. The median total duration of norepinephrine infusion was almost 4 hours. One patient (2.7%, 95% confidence interval 0.5%, 13.8%) had suspected extravasation from a 24‐gauge intravenous catheter in the hand, with local skin hypoperfusion. Skin changes were noted after 135 minutes of norepinephrine infusion. Perfusion normalized after catheter removal, and there were no other sequelae. CONCLUSIONS: In a 3‐year sample of pediatric patients from a large metropolitan area, we found only 1 patient with evidence of any harm with peripheral administration of norepinephrine. This finding is consistent with the adult literature but requires multicenter and multiyear investigation before a firm recommendation for this practice can be made.
format Online
Article
Text
id pubmed-7926000
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-79260002021-03-12 Safety of early norepinephrine infusion through peripheral vascular access during transport of critically ill children Charbel, Ramy C. Ollier, Vincent Julliand, Sebastien Jourdain, Gilles Lode, Noëlla Tissieres, Pierre Morin, Luc J Am Coll Emerg Physicians Open Pediatrics STUDY OBJECTIVE: In prehospital and emergency settings, vasoactive medications may need to be started through a peripheral intravenous catheter. Fear of extravasation and skin injury, with norepinephrine specifically, may prevent or delay peripheral vasopressor initiation, though studies from adults suggest the actual risk is low. We sought to study the risk of extravasation and skin injury with peripheral administration of norepinephrine in children in the prehospital setting. METHODS: We performed a retrospective study of pediatric patients (≤18 years) who received a vasopressor during prehospital transport. We collected data from retrieval and hospital records from 2 pediatric medical retrieval teams in the Paris/Ile‐de‐France region. Patients were eligible if they had documentation of distributive or obstructive shock and administration of norepinephrine through a peripheral catheter (intravenous or intraosseous) during retrieval. The primary outcomes were the occurrence of extravasation and evidence of skin injury. We also examined approach to norepinephrine administration (concentration, duration, proximal vs distal site) and hospital outcomes. RESULTS: Over a 3‐year‐period, 37 pediatric patients received norepinephrine through a peripheral catheter (33 intravenous, 4 intraosseous). Median patient age was 1.8 years. Thirty‐two patients (86.5%) had septic shock. The median total duration of norepinephrine infusion was almost 4 hours. One patient (2.7%, 95% confidence interval 0.5%, 13.8%) had suspected extravasation from a 24‐gauge intravenous catheter in the hand, with local skin hypoperfusion. Skin changes were noted after 135 minutes of norepinephrine infusion. Perfusion normalized after catheter removal, and there were no other sequelae. CONCLUSIONS: In a 3‐year sample of pediatric patients from a large metropolitan area, we found only 1 patient with evidence of any harm with peripheral administration of norepinephrine. This finding is consistent with the adult literature but requires multicenter and multiyear investigation before a firm recommendation for this practice can be made. John Wiley and Sons Inc. 2021-03-02 /pmc/articles/PMC7926000/ /pubmed/33718927 http://dx.doi.org/10.1002/emp2.12395 Text en © 2021 The Authors. JACEP Open published by Wiley Periodicals LLC on behalf of American College of Emergency Physicians This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Pediatrics
Charbel, Ramy C.
Ollier, Vincent
Julliand, Sebastien
Jourdain, Gilles
Lode, Noëlla
Tissieres, Pierre
Morin, Luc
Safety of early norepinephrine infusion through peripheral vascular access during transport of critically ill children
title Safety of early norepinephrine infusion through peripheral vascular access during transport of critically ill children
title_full Safety of early norepinephrine infusion through peripheral vascular access during transport of critically ill children
title_fullStr Safety of early norepinephrine infusion through peripheral vascular access during transport of critically ill children
title_full_unstemmed Safety of early norepinephrine infusion through peripheral vascular access during transport of critically ill children
title_short Safety of early norepinephrine infusion through peripheral vascular access during transport of critically ill children
title_sort safety of early norepinephrine infusion through peripheral vascular access during transport of critically ill children
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926000/
https://www.ncbi.nlm.nih.gov/pubmed/33718927
http://dx.doi.org/10.1002/emp2.12395
work_keys_str_mv AT charbelramyc safetyofearlynorepinephrineinfusionthroughperipheralvascularaccessduringtransportofcriticallyillchildren
AT olliervincent safetyofearlynorepinephrineinfusionthroughperipheralvascularaccessduringtransportofcriticallyillchildren
AT julliandsebastien safetyofearlynorepinephrineinfusionthroughperipheralvascularaccessduringtransportofcriticallyillchildren
AT jourdaingilles safetyofearlynorepinephrineinfusionthroughperipheralvascularaccessduringtransportofcriticallyillchildren
AT lodenoella safetyofearlynorepinephrineinfusionthroughperipheralvascularaccessduringtransportofcriticallyillchildren
AT tissierespierre safetyofearlynorepinephrineinfusionthroughperipheralvascularaccessduringtransportofcriticallyillchildren
AT morinluc safetyofearlynorepinephrineinfusionthroughperipheralvascularaccessduringtransportofcriticallyillchildren